【摘要】 目的探讨维拉帕米在经桡动脉心脏介入治疗中的应用及安全性。方法 60例经桡动脉心脏介入治疗的患者,从桡动脉局部注入维拉帕米5mg,观察注入前、后心率、血压、局部和全身的变化及术中是否出现桡动脉痉挛。结果 60例患者注药前后心率、收缩压、舒张压均有一定程度变化,但无统计学意义(P>0.05),术中未出现桡动脉痉挛,无心衰和新的房室传导阻滞出现。结论在经桡动脉心脏介入治疗时,局部注入维拉帕米5mg,可预防桡动脉痉挛,且无明显不良反应,安全有效。更多还原

【Abstract】 Objective To evaluate the security of verapamil in transradial catheterizati on procedures.Methods Totally 60 patients submitted to a transradial cardiac catheterization were assigned to receive 5 mg of verapamil after sheath insertion.To investigate the heart rate,blood pressure,region and whole reaction at pre-and after-inject verapamil,whether radial artery spasm occurs during the transradial approach for coronary catheterization.Results The heart rate,blood pressure,region and whole reaction at pre-and after-inject verapamil have various changes but have no significant difference.And no radial artery spasm,congestive heart failure and new atrial ventricular block occur during the transradial approach for coronary catheterization.Conclusions Use 5 mg verapamil in transradial catheterization procedures is safety and efficiency,which can prevent radial artery spasm occurs,and no significant adverse reaction.更多还原